IP Library Granted Patent US 8,623,811
Granted Patent B2
US 8,623,811 · App. 12/669,705 · Granted Jan 7, 2014

Antimicrobial peptide, compositions, and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,623,811
App. No.
12/669,705
Granted
Jan 7, 2014
Kind
B2
Abstract

The present invention provides antimicrobial peptides that exhibit a broad range of antimicrobial activity to gram positive and gram negative bacteria, as well as fungi, mold, and virus. The antimicrobial peptide of the invention is a cationic peptide, and may contain an HIV-TAT or reverse HIV-TAT sequence, or derivative thereof. The present invention further provides antimicrobial compositions containing the cationic peptide. Such compositions are especially useful for topical application to the skin, hair, nail, vagina, urethra, ear, oral cavity, nasal passage, respiratory system, opthalmic region, and various mucosal regions. The compositions of the present invention improve the condition and/or appearance of the treated region, and are suited for long-term and/or routine use to, for example, prevent or prevent the recurrence of microbial infection. The present invention further provides kits for use in improving the condition or appearance of skin, nail, or treated area. These kits may facilitate ease of use, long-term storage, and/or efficacy of the compositions.

Claims (67)

1. A pharmaceutical composition comprising a cationic peptide, wherein the cationic peptide comprises an amino acid sequence selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, and SEQ ID NO: 5 and a pharmaceutically or cosmetically acceptable carrier and/or diluent.

2. The composition according to claim 1 , wherein the cationic peptide comprises the amino acid sequence of SEQ ID NO: 3.

3. The composition according to claim 1 , wherein the cationic peptide comprises the amino acid sequence of SEQ ID NO: 4.

4. The composition according to claim 1 , wherein the cationic peptide comprises the amino acid sequence of SEQ ID NO: 5.

5. The composition according to claim 2 , wherein the composition is a topical composition.

6. The composition according to claim 3 , wherein the composition is a topical composition.

7. The composition according to claim 4 , wherein the composition is a topical composition.

8. A kit for administering a composition, the kit comprising

the composition according to claim 2 and

a dispenser.

9. A kit for administering a composition, the kit comprising

the composition according to claim 3 and

a dispenser.

10. A kit for administering a composition, the kit comprising

the composition according to claim 4 and

a dispenser.

11. A kit for administering a composition, the kit comprising

the composition according to claim 5 and

a dispenser.

12. A kit for administering a composition, the kit comprising

the composition according to claim 6 and

a dispenser.

13. A kit for administering a composition, the kit comprising

the composition according to claim 7 and

a dispenser.

14. The composition according to claim 5 , wherein the composition is selected from the group consisting of solid compositions, liquid compositions, solutions, emulsions, microemulsions, suspensions, creams, lotions, gels, powders, and nasal sprays.

15. The composition according to claim 14 , wherein the composition is a solution.

16. The composition according to claim 14 , wherein the composition is a cream.

17. The composition according to claim 14 , wherein the composition is a lotion.

18. The composition according to claim 14 , wherein the composition is a gel.

19. The composition according to claim 14 , wherein the composition is a nasal spray.

20. The composition according to claim 6 , wherein the composition is selected from the group consisting of solid compositions, liquid compositions, solutions, emulsions, microemulsions, suspensions, creams, lotions, gels, powders, and nasal sprays.

21. The composition according to claim 20 , wherein the composition is a solution.

22. The composition according to claim 20 , wherein the composition is a cream.

23. The composition according to claim 20 , wherein the composition is a lotion.

24. The composition according to claim 20 , wherein the composition is a gel.

25. The composition according to claim 20 , wherein the composition is a nasal spray.

26. The composition according to claim 7 , wherein the composition is selected from the group consisting of solid compositions, liquid compositions, solutions, emulsions, microemulsions, suspensions, creams, lotions, gels, powders, and nasal sprays.

27. The composition according to claim 26 , wherein the composition is a solution.

28. The composition according to claim 26 , wherein the composition is a cream.

29. The composition according to claim 26 , wherein the composition is a lotion.

30. The composition according to claim 26 , wherein the composition is a gel.

31. The composition according to claim 26 , wherein the composition is a nasal spray.

32. The composition according to claim 2 , wherein the composition contains from about 0.01% w/v to about 20% w/v cationic peptide.

33. The composition according to claim 3 , wherein the composition contains from about 0.01% w/v to about 20% w/v cationic peptide.

34. The composition according to claim 4 , wherein the composition contains from about 0.01% w/v to about 20% w/v cationic peptide.

35. The composition according to claim 5 , wherein the composition contains from about 0.01% w/v to about 20% w/v cationic peptide.

36. The composition according to claim 6 , wherein the composition contains from about 0.01% w/v to about 20% w/v cationic peptide.

37. The composition according to claim 7 , wherein the composition contains from about 0.01% w/v to about 20% w/v cationic peptide.

38. The kit according to claim 8 , further comprising a component to facilitate application of the composition.

39. The kit according to claim 38 , wherein said component to facilitate application is selected from the group consisting of a brush, a sponge, and a cotton swab.

40. The kit according to claim 9 , further comprising a component to facilitate application of the composition.

41. The kit according to claim 40 , wherein said component to facilitate application is selected from the group consisting of a brush, a sponge, and a cotton swab.

42. The kit according to claim 10 , further comprising a component to facilitate application of the composition.

43. The kit according to claim 42 , wherein said component to facilitate application is selected from the group consisting of a brush, a sponge, and a cotton swab.

44. The kit according to claim 11 , further comprising a component to facilitate application of the composition.

45. The kit according to claim 44 , wherein said component to facilitate application is selected from the group consisting of a brush, a sponge, and a cotton swab.

46. The kit according to claim 12 , further comprising a component to facilitate application of the composition.

47. The kit according to claim 46 , wherein said component to facilitate application is selected from the group consisting of a brush, a sponge, or a cotton swab.

48. The kit according to claim 13 , further comprising a component to facilitate application of the composition.

49. The kit according to claim 48 , wherein said component to facilitate application is selected from the group consisting of a brush, a sponge, or a cotton swab.

50. A cationic peptide comprising the amino acid sequence of SEQ ID NO: 3.

51. The cationic peptide according to claim 50 , wherein said peptide consists of the amino acid sequence of SEQ ID NO: 3.

52. A cationic peptide comprising the amino acid sequence of SEQ ID NO: 4.

53. The cationic peptide according to claim 52 , wherein said peptide consists of the amino acid sequence of SEQ ID NO: 4.

54. A cationic peptide comprising the amino acid sequence of SEQ ID NO: 5.

55. The cationic peptide according to claim 54 , wherein said peptide consists of the amino acid sequence of SEQ ID NO: 5.

Assignments (10)
SECURITY INTEREST Recorded Feb 17, 2025
From: REVANCE THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 070239/0739 →
RELEASE OF SECURITY INTEREST Recorded Feb 7, 2025
From: ATHYRIUM BUFFALO LP
To: REVANCE THERAPEUTICS, INC
Reel/Frame 070153/0630 →
SECURITY INTEREST Recorded Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; BELLUS MEDICAL, LLC; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0736 →
SECURITY INTEREST Recorded Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0663 →
SECURITY INTEREST Recorded Mar 18, 2022
From: REVANCE THERAPEUTICS, INC.
To: ATHYRIUM BUFFALO LP
Reel/Frame 059437/0654 →
RELEASE OF SECURITY INTEREST Recorded Sep 27, 2019
From: HERCULES CAPITAL, INC. (F/K/A HERCULES TECHNOLOGY GROWTH CAPITAL, INC.)
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 050565/0300 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 24432/321, 24432/284, 24432/317, 22432/187, AND 22756/549 Recorded Oct 4, 2011
From: LEADER VENTURES, LLC
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 027015/0658 →
SECURITY AGREEMENT Recorded Sep 22, 2011
From: REVANCE THERAPEUTICS, INC.
To: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
Reel/Frame 026953/0726 →
SECURITY AGREEMENT Recorded May 24, 2010
From: REVANCE THERAPEUTICS, INC.
To: LEADER VENTURES, LLC
Reel/Frame 024432/0321 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2010
From: STONE, HONGRAN FAN; WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 023889/0346 →